Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles
- PMID: 26801064
- DOI: 10.1016/j.vaccine.2016.01.019
Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles
Abstract
Outer Membrane Vesicles (OMVs) are gaining attention as vaccine candidates. The successful expression of heterologous antigens in OMVs, with the OMV functioning both as adjuvant and delivery vehicle, has greatly enhanced their vaccine potential. Since there are indications that surface exposed antigens might induce a superior immune response, targeting of heterologous antigens to the OMV surface is of special interest. Several systems for surface display of heterologous antigens on OMVs have been developed. However, these systems have not been used to display lipidated membrane-associated proteins known as lipoproteins, which are emerging as key targets for protective immunity. We were therefore interested to see whether we could express a foreign lipoprotein on the outer surface of OMVs. When outer surface protein A (OspA), a borrelial surface-exposed lipoprotein, was expressed in meningococci, it was found that although OspA was present in OMVs, it was no longer surface-exposed. Therefore, a set of fusions of OspA to different regions of factor H binding protein (fHbp), a meningococcal surface-exposed lipoprotein, were designed and tested for their surface-exposure. An N-terminal part of fHbp was found to be necessary for the successful surface display of OspA on meningococcal OMVs. When mice were immunized with this set of OMVs, an OspA-specific antibody response was only elicited by OMVs with clearly surface-exposed OspA, strengthening the idea that the exact positioning of an antigen in the OMV affects the immune response. This method for the surface display of heterologous lipoproteins on OMVs is a step forward in the development of OMVs as a vaccine platform.
Keywords: Borrelia burgdorferi; Heterologous expression; Lipoprotein; Neisseria meningitidis; OMV; OspA; Outer Membrane Vesicles; Surface display; fHbp.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis.Vaccine. 2021 Apr 28;39(18):2561-2567. doi: 10.1016/j.vaccine.2021.03.059. Epub 2021 Apr 1. Vaccine. 2021. PMID: 33812741
-
Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.Vaccine. 2019 Nov 8;37(47):6978-6986. doi: 10.1016/j.vaccine.2019.01.076. Epub 2019 Aug 2. Vaccine. 2019. PMID: 31383485
-
Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.Appl Environ Microbiol. 2023 Mar 29;89(3):e0204722. doi: 10.1128/aem.02047-22. Epub 2023 Feb 21. Appl Environ Microbiol. 2023. PMID: 36809058 Free PMC article.
-
Protective immunity elicited by rBCG vaccines.Dev Biol Stand. 1994;82:163-70. Dev Biol Stand. 1994. PMID: 7958471 Review.
-
Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.Expert Rev Vaccines. 2011 Mar;10(3):323-34. doi: 10.1586/erv.11.10. Expert Rev Vaccines. 2011. PMID: 21434800 Review.
Cited by
-
In silico identification and modification of T cell epitopes in pertussis antigens associated with tolerance.Hum Vaccin Immunother. 2020;16(2):277-285. doi: 10.1080/21645515.2019.1703453. Epub 2020 Jan 17. Hum Vaccin Immunother. 2020. PMID: 31951773 Free PMC article.
-
Biological Nanoparticles in Vaccine Development.Front Bioeng Biotechnol. 2022 Mar 23;10:867119. doi: 10.3389/fbioe.2022.867119. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35402394 Free PMC article. Review.
-
Effective Platform for the Production of Recombinant Outer Membrane Vesicles in Gram-Negative Bacteria.J Microbiol Biotechnol. 2022 May 28;32(5):621-629. doi: 10.4014/jmb.2003.03023. J Microbiol Biotechnol. 2022. PMID: 32522965 Free PMC article.
-
Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance.mBio. 2021 Aug 31;12(4):e0170721. doi: 10.1128/mBio.01707-21. Epub 2021 Aug 10. mBio. 2021. PMID: 34372691 Free PMC article. Review.
-
Surface Modification of E. coli Outer Membrane Vesicles with Glycosylphosphatidylinositol-Anchored Proteins: Generating Pro/Eukaryote Chimera Constructs.Membranes (Basel). 2021 Jun 4;11(6):428. doi: 10.3390/membranes11060428. Membranes (Basel). 2021. PMID: 34199851 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources